Updated Jul 16, 2026
Bailey Gregory has filed 3 SEC Form 4 filings across 2 companies in the last 90 days — buying. Lifetime open-market purchases: $18K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-22 | SER | Serina Therapeutics, Inc. | J — Other acquisition / disposition | 6.67M | $2.25 | $15.00M |
| 2026-06-22 | SER | Serina Therapeutics, Inc. | J — Other acquisition / disposition | 1.77M | $2.25 | $3.98M |
| 2026-04-21 | SER | Serina Therapeutics, Inc. | A — Grant or award | 59.7K | $1.94 | $116K |
| 2024-12-19 | SER | Serina Therapeutics, Inc. | P — Open-market purchase | 3.9K | $4.59 | $18K |
Bailey Gregory is a corporate insider — currently tracked as Director of Serina Therapeutics, Inc. (SER). InsiderAlpha tracks every SEC Form 4 filing in real time.
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 1 open-market purchases ($18K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Bailey Gregory profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.